Late Friday afternoon, the Ontario Ministry of Health notified Regional HIV/AIDS Connection (RHAC) that it will terminate provincial funding for the Consumption and Treatment Services (CTS) site located at 446 York Street in London, operated by RHAC. The Ministry has indicated the funding agreement will end on June 13, 2026.
London’s CTS program has been in operation since 2019 and providing supervised consumption services, overdose response, and connections to health and social supports for people who use drugs in London.
This is deeply concerning news for our community and for the people who rely on these services. Carepoint exists because our community has been facing an unprecedented overdose crisis, and the site has played an important role in preventing deaths and connecting people to care.
RHAC is currently reviewing the Ministry’s notice and working to understand the full implications of the decision. Over the coming days, the organization will begin discussions with staff, partners, and public health leaders regarding next steps and continuity of care for individuals who rely on the service.
Evidence from across Canada and internationally has consistently shown that supervised consumption services reduce overdose deaths and the transmission of HIV and hepatitis C, while connecting people to treatment and health services. In London:
- There were zero new HIV infections related to drug use in 2025.
- Carepoint recorded more than 15,000 visits in 2025.
- Staff responded to and reversed 218 overdoses.
These services exist because they save lives. Our focus now is ensuring the people who rely on Carepoint continue to receive support and care during this transition.
RHAC will provide further updates as more information becomes available.